These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32999071)
1. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy. Xue J; Patergnani S; Giorgi C; Suarez J; Goto K; Bononi A; Tanji M; Novelli F; Pastorino S; Xu R; Caroccia N; Dogan AU; Pass HI; Tognon M; Pinton P; Gaudino G; Mak TW; Carbone M; Yang H Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25543-25552. PubMed ID: 32999071 [TBL] [Abstract][Full Text] [Related]
2. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Yang H; Rivera Z; Jube S; Nasu M; Bertino P; Goparaju C; Franzoso G; Lotze MT; Krausz T; Pass HI; Bianchi ME; Carbone M Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12611-6. PubMed ID: 20616036 [TBL] [Abstract][Full Text] [Related]
3. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma. Suarez JS; Novelli F; Goto K; Ehara M; Steele M; Kim JH; Zolondick AA; Xue J; Xu R; Saito M; Pastorino S; Minaai M; Takanishi Y; Emi M; Pagano I; Wakeham A; Berger T; Pass HI; Gaudino G; Mak TW; Carbone M; Yang H Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307999120. PubMed ID: 37729199 [TBL] [Abstract][Full Text] [Related]
4. Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review. Zolondick AA; Gaudino G; Xue J; Pass HI; Carbone M; Yang H Precis Cancer Med; 2021 Sep; 4():. PubMed ID: 35098108 [TBL] [Abstract][Full Text] [Related]
5. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616 [TBL] [Abstract][Full Text] [Related]
6. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. Qi F; Okimoto G; Jube S; Napolitano A; Pass HI; Laczko R; Demay RM; Khan G; Tiirikainen M; Rinaudo C; Croce A; Yang H; Gaudino G; Carbone M Am J Pathol; 2013 Nov; 183(5):1654-66. PubMed ID: 24160326 [TBL] [Abstract][Full Text] [Related]
7. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos. Novelli F; Bononi A; Wang Q; Bai F; Patergnani S; Kricek F; Haglund E; Suarez JS; Tanji M; Xu R; Takanishi Y; Minaai M; Pastorino S; Morris P; Sakamoto G; Pass HI; Barbour H; Gaudino G; Giorgi C; Pinton P; Onuchic JN; Yang H; Carbone M Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34815344 [TBL] [Abstract][Full Text] [Related]
8. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Yang H; Bocchetta M; Kroczynska B; Elmishad AG; Chen Y; Liu Z; Bubici C; Mossman BT; Pass HI; Testa JR; Franzoso G; Carbone M Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10397-10402. PubMed ID: 16798876 [TBL] [Abstract][Full Text] [Related]
9. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Prevents Asbestos-Induced Inflammation and Genotoxic Cell Damage in Human Mesothelial Cells. Pietrofesa RA; Chatterjee S; Kadariya Y; Testa JR; Albelda SM; Christofidou-Solomidou M Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077483 [TBL] [Abstract][Full Text] [Related]
10. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Jube S; Rivera ZS; Bianchi ME; Powers A; Wang E; Pagano I; Pass HI; Gaudino G; Carbone M; Yang H Cancer Res; 2012 Jul; 72(13):3290-301. PubMed ID: 22552293 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Carbone M; Yang H Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079 [TBL] [Abstract][Full Text] [Related]
12. Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. Tabata C; Kanemura S; Tabata R; Masachika E; Shibata E; Otsuki T; Nishizaki T; Nakano T J Clin Gastroenterol; 2013 Sep; 47(8):684-8. PubMed ID: 23685846 [TBL] [Abstract][Full Text] [Related]
13. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Pellegrini L; Xue J; Larson D; Pastorino S; Jube S; Forest KH; Saad-Jube ZS; Napolitano A; Pagano I; Negi VS; Bianchi ME; Morris P; Pass HI; Gaudino G; Carbone M; Yang H Oncotarget; 2017 Apr; 8(14):22649-22661. PubMed ID: 28186988 [TBL] [Abstract][Full Text] [Related]
14. p53/HMGB1 complexes regulate autophagy and apoptosis. Livesey KM; Kang R; Vernon P; Buchser W; Loughran P; Watkins SC; Zhang L; Manfredi JJ; Zeh HJ; Li L; Lotze MT; Tang D Cancer Res; 2012 Apr; 72(8):1996-2005. PubMed ID: 22345153 [TBL] [Abstract][Full Text] [Related]
15. Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma. Carbone M; Minaai M; Takinishi Y; Pagano I; Yang H J Transl Med; 2023 Oct; 21(1):749. PubMed ID: 37880686 [TBL] [Abstract][Full Text] [Related]
16. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma. Wang Y; Jiang Z; Yan J; Ying S Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101 [TBL] [Abstract][Full Text] [Related]